Table 3 Multivariate Cox regression model fitting results by acceptance of chemotherapy in advanced PDAC patients
From: Prognostic relevance of lactate dehydrogenase in advanced pancreatic ductal adenocarcinoma patients
Independent variables | Chemotherapy group | Non-chemotherapy group | ||
|---|---|---|---|---|
Crude HR (95% CI) | Adjusted HR (95% CI) | Crude HR (95% CI) | Adjusted HR (95% CI) | |
Age at diagnosis (+5 years) | 1.09 (0.94–1.25) | 1.06 (0.94–1.20) | 1.17 (1.03–1.33) | 1.14 (1.00–1.30) |
Sex (Male) | 0.64 (0.38–1.07) | 0.67 (0.39–1.14) | 0.90 (0.53–1.55) | 0.89 (0.50–1.56) |
Baseline albumin (Decreased) | 3.14 (1.67–5.89) | 3.27 (1.70–6.27) | 1.24 (0.62–2.47) | 1.06 (0.51–2.21) |
Baseline LDH (Elevated) | 2.34 (1.23–4.45) | 2.47 (1.28–4.77) | 1.91 (1.04–3.47) | 1.57 (0.83–2.96) |